Psychological Screening and Nursing of Twin Pregnancy

January 17, 2022 updated by: Caixia Liu, Shengjing Hospital
Objectives This research will screen the psychological problems of twin pregnant women step by step and detect early and treat early in order to reduce the incidence of mental diseases and promote the health of mother and baby.

Study Overview

Detailed Description

Method Twin pregnant women recruited for the study.The two groups were given routine treatment and nursing measures. The trained group members were given routine psychological care to the control group, while the intervention group was given step-by-step psychological care at the same time.

Evaluate the effect

  1. Evaluation methods include process evaluation and result evaluation. Process assessment means that the researchers use the pregnancy stress scale, self rating depression scale and self rating anxiety scale to assess the stress, anxiety and depression of patients at different stages, and make intervention decisions according to the score results; Results evaluation means that if the intervention is effective at a certain stage, the researcher can use it again
  2. The evaluation indexes included PPS / SAS / SDS, incidence of preterm birth, premature rupture of membranes and blood pressure.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Liaoning
      • Shenyang, Liaoning, China, 110004
        • Recruiting
        • Shengjing Hospital affiliated to China Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Clinical diagnosis of intrauterine twin pregnancy.
  • The patients whose psychological screening scale score reached the critical value (pregnancy stress scale >50 and/or Self rating depression scale ≥ 40 and/or The self rating Anxiety Scale (SAS) was more than 50.
  • The outpatient department of the research hospital was established and antenatal examination was carried out regularly.
  • No mental and communication disorders (including depression and other mental diseases).
  • Voluntary participation in this study

Exclusion Criteria:

  • Pregnancy complicated with severe physical diseases;
  • Drop out of this study due to various reasons (including abortion, unwilling to participate in this study)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Guided self help
Introduce the knowledge about twins pregnancy, and reduce the pregnant stress, and relief the anxiety and depressor.
Introduce the knowledge about twins pregnancy, and reduce the pregnant stress, and relief the anxiety and depressor.
Based on the steps of problem-solving therapy, nurses guide mothers with mild psychological problems to solve the existing problems through wechat and telephone, 10-15 min each time for 4 weeks
Experimental: Face to face PST course
Problem cognition and emotional response guidance
Based on the steps of problem-solving therapy, nurses guide mothers with mild psychological problems to solve the existing problems through wechat and telephone, 10-15 min each time for 4 weeks
Face to face interviews with nurses with psychological counselors, combined with auxiliary tools, identify patients' problems, set goals for patients, provide different solutions, and let patients choose appropriate ways according to their preferences. Once a week, 1 hour for the first time and 45 min for the rest for 5 weeks.
Experimental: Professional psychological intervention
Give the pregnancy woman the professional psychological intervention
The mental health physicians and (or) psychological counselors strengthened the intervention and carried out specialized nursing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pregnancy stress scale Self rating Anxiety Scale Depression self rating scale(PPS/SAS/SDS)
Time Frame: pregnancy 6-14 week
If scores are less than 50, it is defined as normal; If scores are 50-59, it is defined as mild pregnancy stress; If scores are 60-69, it is defined as moderate pressure; If scores are ≥70, it is defined as severe pregnancy stress
pregnancy 6-14 week
Self-rating Anxiety Scale (SAS)
Time Frame: pregnancy 6-14 week
If scores are less than 50, it is defined as normal; If scores are 50-59, it is defined as mild anxiety; If scores are 60-69, it is defined as moderate anxiety; If scores are ≥70, it is defined as severe anxiety.
pregnancy 6-14 week
Self-rating Depression Scale (SDS)
Time Frame: pregnancy 6-14 week
If scores are less than 50, it is defined as normal; If scores are 50-59, it is defined as mild depression; If scores are 60-69, it is defined as moderate depression; If scores are ≥70, it is defined as severe depression
pregnancy 6-14 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-rating Anxiety Scale (SAS)
Time Frame: 28-37 weeks; after delivery 1 month
If scores are less than 50, it is defined as normal; If scores are 50-59, it is defined as mild anxiety; If scores are 60-69, it is defined as moderate anxiety; If scores are ≥70, it is defined as severe anxiety.
28-37 weeks; after delivery 1 month
Self-rating Depression Scale (SDS)
Time Frame: 28-37 weeks; after delivery 1 month
If scores are less than 50, it is defined as normal; If scores are 50-59, it is defined as mild depression; If scores are 60-69, it is defined as moderate depression; If scores are ≥70, it is defined as severe depression
28-37 weeks; after delivery 1 month
Pregnancy stress scale
Time Frame: 28-37 weeks; after delivery 1 month
If scores are less than 50, it is defined as normal; If scores are50-59, it is defined as mild pregnancy stress; If scores are 60-69, it is defined as moderate pressure; If scores are ≥70, it is defined as severe pregnancy stress
28-37 weeks; after delivery 1 month
Gestational age and prolongation of gestational age at delivery
Time Frame: 28-37 weeks; after delivery 1 month
Gestational age at which symptoms of preterm birth occur and gestational age at delivery after treatment
28-37 weeks; after delivery 1 month
Weight in kilogram of neonate
Time Frame: At birth of neonate
measured by nurses
At birth of neonate

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2021

Primary Completion (Anticipated)

July 1, 2026

Study Completion (Anticipated)

December 31, 2026

Study Registration Dates

First Submitted

June 27, 2021

First Submitted That Met QC Criteria

December 20, 2021

First Posted (Actual)

January 10, 2022

Study Record Updates

Last Update Posted (Actual)

January 19, 2022

Last Update Submitted That Met QC Criteria

January 17, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PST in TP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Research results and conclusions

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Twin; Complicating Pregnancy

Clinical Trials on Guided self help

Subscribe